Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice.
BACKGROUND: Pandemic influenza poses a serious threat to global health and the world economy. While vaccines are currently under development, passive immunization could offer an alternative strategy to prevent and treat influenza virus infection. Attempts to develop monoclonal antibodies (mAbs) have...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2854139?pdf=render |
id |
doaj-a70752a7f957440aba4c48e37aea5ad1 |
---|---|
record_format |
Article |
spelling |
doaj-a70752a7f957440aba4c48e37aea5ad12020-11-24T21:55:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-01-0154e1015210.1371/journal.pone.0010152Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice.Huan H NguyenTerrence M TumpeyHae-Jung ParkYoung-Ho ByunLinh D TranVan D NguyenPaul E KilgoreCecil CzerkinskyJacqueline M KatzBaik Lin SeongJae Min SongYoung Bong KimHoa T DoTung NguyenCam V NguyenBACKGROUND: Pandemic influenza poses a serious threat to global health and the world economy. While vaccines are currently under development, passive immunization could offer an alternative strategy to prevent and treat influenza virus infection. Attempts to develop monoclonal antibodies (mAbs) have been made. However, passive immunization based on mAbs may require a cocktail of mAbs with broader specificity in order to provide full protection since mAbs are generally specific for single epitopes. Chicken immunoglobulins (IgY) found in egg yolk have been used mainly for treatment of infectious diseases of the gastrointestinal tract. Because the recent epidemic of highly pathogenic avian influenza virus (HPAIV) strain H5N1 has resulted in serious economic losses to the poultry industry, many countries including Vietnam have introduced mass vaccination of poultry with H5N1 virus vaccines. We reasoned that IgY from consumable eggs available in supermarkets in Vietnam could provide protection against infections with HPAIV H5N1. METHODS AND FINDINGS: We found that H5N1-specific IgY that are prepared from eggs available in supermarkets in Vietnam by a rapid and simple water dilution method cross-protect against infections with HPAIV H5N1 and related H5N2 strains in mice. When administered intranasally before or after lethal infection, the IgY prevent the infection or significantly reduce viral replication resulting in complete recovery from the disease, respectively. We further generated H1N1 virus-specific IgY by immunization of hens with inactivated H1N1 A/PR/8/34 as a model virus for the current pandemic H1N1/09 and found that such H1N1-specific IgY protect mice from lethal influenza virus infection. CONCLUSIONS: The findings suggest that readily available H5N1-specific IgY offer an enormous source of valuable biological material to combat a potential H5N1 pandemic. In addition, our study provides a proof-of-concept for the approach using virus-specific IgY as affordable, safe, and effective alternative for the control of influenza outbreaks, including the current H1N1 pandemic.http://europepmc.org/articles/PMC2854139?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Huan H Nguyen Terrence M Tumpey Hae-Jung Park Young-Ho Byun Linh D Tran Van D Nguyen Paul E Kilgore Cecil Czerkinsky Jacqueline M Katz Baik Lin Seong Jae Min Song Young Bong Kim Hoa T Do Tung Nguyen Cam V Nguyen |
spellingShingle |
Huan H Nguyen Terrence M Tumpey Hae-Jung Park Young-Ho Byun Linh D Tran Van D Nguyen Paul E Kilgore Cecil Czerkinsky Jacqueline M Katz Baik Lin Seong Jae Min Song Young Bong Kim Hoa T Do Tung Nguyen Cam V Nguyen Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS ONE |
author_facet |
Huan H Nguyen Terrence M Tumpey Hae-Jung Park Young-Ho Byun Linh D Tran Van D Nguyen Paul E Kilgore Cecil Czerkinsky Jacqueline M Katz Baik Lin Seong Jae Min Song Young Bong Kim Hoa T Do Tung Nguyen Cam V Nguyen |
author_sort |
Huan H Nguyen |
title |
Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. |
title_short |
Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. |
title_full |
Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. |
title_fullStr |
Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. |
title_full_unstemmed |
Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. |
title_sort |
prophylactic and therapeutic efficacy of avian antibodies against influenza virus h5n1 and h1n1 in mice. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2010-01-01 |
description |
BACKGROUND: Pandemic influenza poses a serious threat to global health and the world economy. While vaccines are currently under development, passive immunization could offer an alternative strategy to prevent and treat influenza virus infection. Attempts to develop monoclonal antibodies (mAbs) have been made. However, passive immunization based on mAbs may require a cocktail of mAbs with broader specificity in order to provide full protection since mAbs are generally specific for single epitopes. Chicken immunoglobulins (IgY) found in egg yolk have been used mainly for treatment of infectious diseases of the gastrointestinal tract. Because the recent epidemic of highly pathogenic avian influenza virus (HPAIV) strain H5N1 has resulted in serious economic losses to the poultry industry, many countries including Vietnam have introduced mass vaccination of poultry with H5N1 virus vaccines. We reasoned that IgY from consumable eggs available in supermarkets in Vietnam could provide protection against infections with HPAIV H5N1. METHODS AND FINDINGS: We found that H5N1-specific IgY that are prepared from eggs available in supermarkets in Vietnam by a rapid and simple water dilution method cross-protect against infections with HPAIV H5N1 and related H5N2 strains in mice. When administered intranasally before or after lethal infection, the IgY prevent the infection or significantly reduce viral replication resulting in complete recovery from the disease, respectively. We further generated H1N1 virus-specific IgY by immunization of hens with inactivated H1N1 A/PR/8/34 as a model virus for the current pandemic H1N1/09 and found that such H1N1-specific IgY protect mice from lethal influenza virus infection. CONCLUSIONS: The findings suggest that readily available H5N1-specific IgY offer an enormous source of valuable biological material to combat a potential H5N1 pandemic. In addition, our study provides a proof-of-concept for the approach using virus-specific IgY as affordable, safe, and effective alternative for the control of influenza outbreaks, including the current H1N1 pandemic. |
url |
http://europepmc.org/articles/PMC2854139?pdf=render |
work_keys_str_mv |
AT huanhnguyen prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT terrencemtumpey prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT haejungpark prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT younghobyun prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT linhdtran prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT vandnguyen prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT paulekilgore prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT cecilczerkinsky prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT jacquelinemkatz prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT baiklinseong prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT jaeminsong prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT youngbongkim prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT hoatdo prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT tungnguyen prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice AT camvnguyen prophylacticandtherapeuticefficacyofavianantibodiesagainstinfluenzavirush5n1andh1n1inmice |
_version_ |
1725860447957024768 |